MEDVi vs PeterMD: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher

Reviewed & updated August 14, 2026 · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

54 providers verified independently·Independent research·How we rank →

Short answer: PeterMD scores higher on our rubric, 7.3/10 against 5.7/10. Full reasoning, pricing and the cases where the other one wins are below.

Visit PeterMD - our pick of these two →or find your match

PeterMD beats MEDVi overall, scoring 7.3/10 vs 5.7/10. Published pricing is not a like-for-like monthly comparison: MEDVi is $179 first month, then $299/mo; PeterMD is from $165/mo. Choose MEDVi for users who want both oral and injectable compounded options in one telehealth program. Choose PeterMD for budget-conscious users looking for the lowest monthly glp-1 cost.

A side-by-side look at MEDVi and PeterMD to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

MEDVi

#46 of 54

5.7/10

MEDVi offers oral and injectable compounded GLP-1 care. Semaglutide is $179 for month one and $299 for refills. Trustpilot is 4.4/5 across roughly 11,000 reviews, while BBB is F/not accredited. FDA warning letter #721455 concerns misleading labeling and marketing, not an allegation that the medication was unsafe.

Visit MEDVi

Higher Rated

PeterMD

#28 of 54

7.3/10

One of the most affordable compounded GLP-1 options on the market, ideal for budget-conscious patients.

Visit PeterMD

Feature	MEDVi	PeterMD
Why each one	Oral and injectable compounded formats in one program, with micro-dosing options and a path to FDA-approved brand medication.	Flat $165/mo pricing at all doses with semaglutide + B12 formulation (B12 helps reduce nausea), backed by 100,000+ patients and 14,000+ Trustpilot reviews.
Our Score	5.7/10	7.3/10
Headline Price	$179 first month, then $299/mo	from $165/mo
Medication Type	Both	Compounded
Insurance Accepted	No	No
Best For	Users who want both oral and injectable compounded options in one telehealth program	Budget-conscious users looking for the lowest monthly GLP-1 cost
Watch out for	FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication	Available in 42 states, not all 50 (8 states are excluded). Check your state during signup before planning around PeterMD.
Ranking	#46	#28
Get started	Visit MEDVi	Visit PeterMD

Pros & Cons Compared

MEDVi

Pros

+One of the few compounded providers offering both oral tablets and injectable semaglutide
+Micro-dosing options available, can start at sub-standard doses for patients concerned about side effects
+Sleek onboarding experience with clear progress tracking through their patient portal
+$179 covers the first month of compounded semaglutide on the current Katalys landing, including clinician review, medication and shipping

Cons

−FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication
−Its third-party records conflict: 4.4/5 across roughly 11,000 Trustpilot reviews, but an F and no accreditation at the BBB
−The $179 semaglutide price is introductory; the current Katalys landing says refills are $299/mo, making the first-year total $3,468 rather than $2,148
−Brand-name Wegovy and Zepbound paths add a $99 membership plus the medication cost, which the current landing does not publish; availability can change
−No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms

PeterMD

Pros

+Flat $165/mo at all dose levels, price doesn't increase as you titrate up to maintenance doses
+100,000+ patient base with 4.9/5 Trustpilot rating from 14,000+ reviews, strong social proof
+Semaglutide + B12 formulation helps reduce nausea, the most common GLP-1 side effect
+Video consultations with physicians included, real face-to-face medical oversight

Cons

−Available in 42 states, not all 50 (8 states are excluded). Check your state during signup before planning around PeterMD.
−Not BBB accredited, and some documented complaints cite delayed medication fulfillment. Order refills ahead of your last dose rather than at the last minute.
−PeterMD began as a testosterone replacement therapy platform; GLP-1 is an expansion, not the original core. The included video consultations give you a direct read on the clinical team.

Our Verdict

PeterMD edges out MEDVi with a score of 7.3/10 vs 5.7/10. Published pricing is not a like-for-like monthly comparison: MEDVi is $179 first month, then $299/mo; PeterMD is from $165/mo. MEDVi offers both brand-name and compounded medications, giving you more flexibility.